This week's Fierce Life Sciences is brought to you by Medpace.

Complimentary Whitepaper Download

Hi E, check out this Fierce Whitepaper we think you'll like:

Advancements in CRISPR-Cas9 Gene Editing for Cardiovascular Disorders

The white paper reviews the:

• Recent developments surrounding CRISPR-Cas9 gene editing technology, particularly concerning its use versus other gene-editing technologies.
• Benefits and challenges of utilizing CRISPR gene editing as therapy for cardiovascular diseases (CVDs) such as Transthyretin Amyloidosis.
• Regulatory considerations for the use of gene editing in treating cardiovascular conditions, particularly relating to the clinical assessment and ethical use of gene-editing techniques.